Cefort-TZ || Ceftriaxone & Tazobactam

PRODUCT NAME : Cefort-TZ

Dosage Form: Injection

Packing: Vial

Ceftriaxone and Tazobactam Injection is a broad-spectrum antibacterial combination formulated to help manage a wide range of bacterial infections. Ceftriaxone, a third-generation cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, while Tazobactam acts as a beta-lactamase inhibitor that helps protect Ceftriaxone from bacterial enzymes that may reduce its effectiveness. Together, they provide enhanced antibacterial activity against susceptible microorganisms.

This injectable formulation is commonly used under medical supervision in hospitals and healthcare settings for the management of respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, bone and joint infections, gynecological infections, and septicemia caused by susceptible bacteria. It is manufactured in WHO-GMP-compliant facilities with strict quality standards to ensure safety, consistency, and reliable performance.

At Biomorph Lifesciences, we manufacture high-quality Ceftriaxone and Tazobactam Injection for third-party manufacturing and PCD pharma franchise businesses. Every batch undergoes rigorous quality control and follows stringent pharmaceutical manufacturing practices to meet industry standards. With secure packaging, timely delivery, and dependable manufacturing support, Biomorph Lifesciences is committed to providing reliable injectable formulations that help pharmaceutical companies expand their product portfolio while maintaining high standards of quality and compliance.

Category:

Description

MORE DETAILS ABOUT PRODUCT

Cefort-TZ 1.125gm

  • A broad-spectrum antibiotic combination containing Ceftriaxone and Tazobactam for the treatment of susceptible bacterial infections.

  • Ceftriaxone inhibits bacterial cell wall synthesis, providing effective bactericidal activity.

  • Tazobactam acts as a beta-lactamase inhibitor, protecting Ceftriaxone from bacterial enzyme degradation and enhancing its antibacterial effectiveness.

  • Effective against a wide range of Gram-positive and Gram-negative bacteria.

  • Commonly prescribed for respiratory tract, urinary tract, skin and soft tissue, bone and joint, intra-abdominal, and gynecological infections.

  • Suitable for intravenous (IV) or intramuscular (IM) administration under the supervision of a qualified healthcare professional.

Also Available


GLIFAB-MP1 / MP2

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg

VYOFAB MP1/MP2

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg

AMLOFAB-50​ AT / 50

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg

GLIFAB-MP1 / MP2

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg

VYOFAB-0.2/0.3

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg


VYOFAB-0.2/0.3

Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg

Indications

Key Benefits of Cefort-TZ || Ceftriaxone & Tazobactam

  • Broad-spectrum antibacterial coverage against Gram-positive and Gram-negative organisms.
  • Dual-action formulation combining Ceftriaxone and Tazobactam for enhanced antibacterial efficacy.
  • Tazobactam inhibits beta-lactamase enzymes, helping restore and extend the activity of Ceftriaxone.
  • Effective against beta-lactamase-producing bacteria, reducing the risk of antibiotic resistance.
  • Suitable for the treatment of respiratory, urinary, skin, bone, joint, and intra-abdominal infections.
  • Provides rapid bactericidal action by inhibiting bacterial cell wall synthesis.
  • Can be administered via Intravenous (IV) or Intramuscular (IM) route under medical supervision.
  • Sterile injectable formulation manufactured under stringent GMP quality standards.
  • Ensures consistent quality, safety, and batch-to-batch reliability.
  •  

Always Trust the Superior BIOMORPH Lifesciences Pvt. Ltd.